Effect of AST-120 treatment discontinuation and serum albumin on free and bound indoxyl sulphate in end-stage kidney disease
Int. Journal of Clinical Pharmacology and Therapeutics · 01.04.2026 · 64 (04) · 181-193
DOI: 10.5414/cp203027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.04.2026. Verfasst von Takuya Yoshida und 16 weiteren Autor:innen. Hauptthemen laut MEDLINE: Indican, Carbon, Kidney Failure, Chronic, Renal Dialysis.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Yoshida, T., Tsujimoto, M., Fujioka, H., Irie, Y., Kawakami, S., Nakatani, S., Iso, A., Sugiyama, A., Miyake, M., Sumino, K., Tanaka, R., Oda, T., Furukubo, T., Izumi, S., Yamakawa, T., Minegaki, T., & Nishiguchi, K. (2026). Effect of AST-120 treatment discontinuation and serum albumin on free and bound indoxyl sulphate in end-stage kidney disease. Int. Journal of Clinical Pharmacology and Therapeutics, 64(04), 181-193. https://doi.org/10.5414/cp203027
Vancouver
Yoshida T, Tsujimoto M, Fujioka H, Irie Y, Kawakami S, Nakatani S, et al. Effect of AST-120 treatment discontinuation and serum albumin on free and bound indoxyl sulphate in end-stage kidney disease. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(04):181-193. doi:10.5414/cp203027
BibTeX
@article{Yoshida2026,
author = {Yoshida, Takuya and Tsujimoto, Masayuki and Fujioka, Haruno and Irie, Yuko and Kawakami, Sachiyo and Nakatani, Saki and Iso, Ayako and Sugiyama, Ayaka and Miyake, Mizuho and Sumino, Kazumi and Tanaka, Rie and Oda, Tomoko and Furukubo, Taku and Izumi, Satoshi and Yamakawa, Tomoyuki and Minegaki, Tetsuya and Nishiguchi, Kohshi},
title = {Effect of AST-120 treatment discontinuation and serum albumin on free and bound indoxyl sulphate in end-stage kidney disease},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {04},
pages = {181--193},
doi = {10.5414/cp203027}
}
EUVIMED